Former CEO of Trius Therapeutics Publishes New Blog Entitled “FDA Drug Approvals: Congress Giveth then Taketh Away”admin
By Market Exclusive Former CEO of Trius Therapeutics, Dr.
Jeffrey Stein, published a new blog post on The Chairman’s Blog.
TheChairmansBlog.com is an exclusive online media publication that
enables key executive officers a unique platform to share insights
about their company and industry trends.
Stein writes about the government shutdown and its likely impact on
companies filing for drug approvals. Read the full blog post from Dr.
Jeffrey Stein on TheChairmansBlog.com
an exclusive, online media publication where publically and
privatively held firms alike share insights about their companies and
industries. TheChairmansBlog.com enables upper tier management to
discuss issues that are of importance to their stakeholders,
shareholders, and interested parties in an informal environment. In
addition to management`s insightful blog posts, TheChairmansBlog.com
staff and aggregate partners contribute articles on finance,
technology, health, and energy while providing updated market trends,
news, and information.
Posted: October 8th, 2013 under ACCESSWIRE.